Interestingly, an earlier study identified that USP22 is one of an 11-gene transcriptional signature which was associated with aggressive growth, metastasis, and therapy resistance in a number of human cancers including lung cancer [8]. This evidence concerns the gene USP22 and lung carcinoma.